Literature DB >> 36071145

Enteric glial cells favor accumulation of anti-inflammatory macrophages during the resolution of muscularis inflammation.

Michelle Stakenborg1, Saeed Abdurahiman1, Veronica De Simone1, Gera Goverse1, Nathalie Stakenborg1, Lies van Baarle1, Qin Wu1, Dimitri Pirottin2, Jung-Seok Kim3, Louise Chappell-Maor3, Isabel Pintelon4, Sofie Thys4, Emilie Pollenus5, Louis Boon6, Philippe Van den Steen5, Marlene Hao1, Jo A Van Ginderachter7,8, Guy E Boeckxstaens1, Jean-Pierre Timmermans4, Steffen Jung3, Thomas Marichal9,10, Sales Ibiza11,12, Gianluca Matteoli13.   

Abstract

Monocyte-derived macrophages (Mφs) are crucial regulators during muscularis inflammation. However, it is unclear which micro-environmental factors are responsible for monocyte recruitment and anti-inflammatory Mφ differentiation in this paradigm. Here, we investigate Mφ heterogeneity at different stages of muscularis inflammation and determine how environmental cues can attract and activate tissue-protective Mφs. Results showed that muscularis inflammation induced marked alterations in mononuclear phagocyte populations associated with a rapid infiltration of Ly6c+ monocytes that locally acquired unique transcriptional states. Trajectory inference analysis revealed two main pro-resolving Mφ subpopulations during the resolution of muscularis inflammation, i.e. Cd206+ MhcIIhi and Timp2+ MhcIIlo Mφs. Interestingly, we found that damage to the micro-environment upon muscularis inflammation resulted in EGC activation, which in turn stimulated monocyte infiltration and the consequent differentiation in anti-inflammatory CD206+ Mφs via CCL2 and CSF1, respectively. In addition, CSF1-CSF1R signaling was shown to be essential for the differentiation of monocytes into CD206+ Mφs and EGC proliferation during muscularis inflammation. Our study provides a comprehensive insight into pro-resolving Mφ differentiation and their regulators during muscularis inflammation. We deepened our understanding in the interaction between EGCs and Mφs, thereby highlighting pro-resolving Mφ differentiation as a potential novel therapeutic strategy for the treatment of intestinal inflammation.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36071145     DOI: 10.1038/s41385-022-00563-2

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   8.701


  47 in total

1.  Publisher Correction: To respond or not to respond - a personal perspective of intestinal tolerance.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2018-08       Impact factor: 53.106

2.  Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis.

Authors:  Sebastiaan De Schepper; Simon Verheijden; Javier Aguilera-Lizarraga; Maria Francesca Viola; Werend Boesmans; Nathalie Stakenborg; Iryna Voytyuk; Inga Schmidt; Bram Boeckx; Isabelle Dierckx de Casterlé; Veerle Baekelandt; Erika Gonzalez Dominguez; Matthias Mack; Inge Depoortere; Bart De Strooper; Ben Sprangers; Uwe Himmelreich; Stefaan Soenen; Martin Guilliams; Pieter Vanden Berghe; Elizabeth Jones; Diether Lambrechts; Guy Boeckxstaens
Journal:  Cell       Date:  2018-08-30       Impact factor: 41.582

3.  Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents.

Authors:  Sven Wehner; Florian F Behrendt; Boris N Lyutenski; Mariola Lysson; Anthony J Bauer; Andreas Hirner; Jörg C Kalff
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

4.  Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis.

Authors:  Ehud Zigmond; Biana Bernshtein; Gilgi Friedlander; Catherine R Walker; Simon Yona; Ki-Wook Kim; Ori Brenner; Rita Krauthgamer; Chen Varol; Werner Müller; Steffen Jung
Journal:  Immunity       Date:  2014-05-01       Impact factor: 31.745

5.  Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria.

Authors:  Usriansyah Hadis; Benjamin Wahl; Olga Schulz; Matthias Hardtke-Wolenski; Angela Schippers; Norbert Wagner; Werner Müller; Tim Sparwasser; Reinhold Förster; Oliver Pabst
Journal:  Immunity       Date:  2011-02-17       Impact factor: 31.745

6.  Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy.

Authors:  Jörg C Kalff; Andreas Türler; Nicolas T Schwarz; Wolfgang H Schraut; Kenneth K W Lee; David J Tweardy; Timothy R Billiar; Richard L Simmons; Anthony J Bauer
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

7.  Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice.

Authors:  Wouter J de Jonge; René M van den Wijngaard; Frans O The; Merel-Linde ter Beek; Roel J Bennink; Guido N J Tytgat; Ruud M Buijs; Pieter H Reitsma; Sander J van Deventer; Guy E Boeckxstaens
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility.

Authors:  Paul Andrew Muller; Balázs Koscsó; Gaurav Manohar Rajani; Korey Stevanovic; Marie-Luise Berres; Daigo Hashimoto; Arthur Mortha; Marylene Leboeuf; Xiu-Min Li; Daniel Mucida; E Richard Stanley; Stephanie Dahan; Kara Gross Margolis; Michael David Gershon; Miriam Merad; Milena Bogunovic
Journal:  Cell       Date:  2014-07-17       Impact factor: 41.582

9.  Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages.

Authors:  Ilana Gabanyi; Paul A Muller; Linda Feighery; Thiago Y Oliveira; Frederico A Costa-Pinto; Daniel Mucida
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

10.  Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes.

Authors:  Kenichi Asano; Naomichi Takahashi; Mikiko Ushiki; Misa Monya; Fumiaki Aihara; Erika Kuboki; Shigetaka Moriyama; Mayumi Iida; Hiroshi Kitamura; Chun-Hong Qiu; Takashi Watanabe; Masato Tanaka
Journal:  Nat Commun       Date:  2015-07-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.